DyNAbind and Pharmacelera are happy to announce a joint scientific collaboration in
As we explained in our previous post, Artificial Intelligence (AI) is more
By Enric Gibert – Feb. 24, 2022 Although the concepts of Artificial
By Silvia Illa – Oct. 26, 2021 It’s been almost a year
Istituto Italiano di Tecnologia (IIT) and Pharmacelera announce that they will collaborate
By Alessandro Deplano – Jan. 9, 2021 Preselecting the final compound after
By Giorgia Zaetta – May. 19, 2021 G protein-coupled receptors (GPCRs), also
Iktoswill apply Pharmacelera’s accurate Quantum-Mechanics (QM) hydrophobic molecular 3D descriptors via the
By Giorgia Zaetta – March. 9, 2021 The challenges of CNS Drug Discovery
By Giorgia Zaetta – Dec. 11, 2020 Lipophilicity is the property of
By Melanie Berg – Nov. 30, 2020 Pharmacelera is proud to announce
By Lluis Campos – Sep. 23, 2020 Molecular Docking is a key
We are happy to announce that PharmScreen, our virtual screening tool is
The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) or COVID-19 has spread
